Results 211 to 220 of about 594,733 (360)
The in vitro Release of Leukocyte Histamine by Staphylococcal Antigens [PDF]
R. Russell Martin, A. Clinton White
openalex +1 more source
This study reveals a novel mechanism of resistance to DNA hypomethylating agents (HMAs) in acute myeloid leukemia (AML), and identifies all‐trans retinoic acid (ATRA) and tamibarotene (TAM) as potent agents that overcome HMA resistance by reactivating the interferon anticancer immune response. The findings offer promising therapeutic strategies for HMA‐
Xueqin Chen+18 more
wiley +1 more source
Effect of leukocytes on transplantability of human cancer [PDF]
Chester M. Southam+3 more
openalex +1 more source
This study investigates hypoglycemia‐induced diabetic macrovascular endothelial dysfunction. It reveals that hypoglycemia triggers ZBP1‐dependent PANoptosis of endothelial cells, proinflammatory polarization of macrophages, and fibrosis of vascular smooth muscle cells (VSMCs) in diabetic mice.
Deyu Zuo+10 more
wiley +1 more source
Restricted human CD45 isoglycoforms serve as functional E-selectin ligands and delineate hematopoietic maturity. [PDF]
Ales E, Sackstein R.
europepmc +1 more source
Demonstration of a Herpes Group Virus in Cultures of Peripheral Leukocytes from Patients with Infectious Mononucleosis [PDF]
Volker Diehl+3 more
openalex +1 more source
WSGC peptide reverses drug resistance in GA by modulating the Notch signaling pathway and mitophagy at the molecular level. Abstract This study investigates the molecular mechanisms by which superparamagnetic iron oxide nanoparticles (SPIONs) loaded with the WSGC peptide (WSGC@FA@PEG/PEI‐SPIONs)—a 40‐amino acid polypeptide derived from apoC‐III ...
Dongjian Song+10 more
wiley +1 more source
Male Breast Cancer Complicated With Leukocytosis Resembling Leukemia Reaction After Chemotherapy: A Case Report. [PDF]
Liu Y, Liu J.
europepmc +1 more source
CHROMOSOME POLYPLOIDIZATION IN HUMAN LEUKOCYTES INDUCED BY RADIATION [PDF]
Carlos E. Nasjleti, Herbert H. Spencer
openalex +1 more source
This study develops an a red/far‐red light‐controlled iPSC‐based vaccines (RIVA) based on the chimeric photosensory protein FnBphP and its interaction partner LDB3 for cancer immunotherapy. The RIVA preserves the multiple intrinsic tumor antigens of iPSCs and enables optogenetic control of the expression of the immune adjuvant type I interferon β under
Longliang Qiao+17 more
wiley +1 more source